Your browser doesn't support javascript.
loading
Cognition, function, and prevalent dementia in centenarians and near-centenarians: An individual participant data (IPD) meta-analysis of 18 studies.
Leung, Yvonne; Barzilai, Nir; Batko-Szwaczka, Agnieszka; Beker, Nina; Boerner, Kathrin; Brayne, Carol; Brodaty, Henry; Cheung, Karen Siu-Lan; Corrada, María M; Crawford, John D; Galbussera, Alessia A; Gondo, Yasuyuki; Holstege, Henne; Hulsman, Marc; Ishioka, Yoshiko Lily; Jopp, Daniela; Kawas, Claudia H; Kaye, Jeff; Kochan, Nicole A; Lau, Bobo Hi-Po; Lipnicki, Darren M; Lo, Jessica W; Lucca, Ugo; Makkar, Steve R; Marcon, Gabriella; Martin, Peter; Meguro, Kenichi; Milman, Sofiya; Poon, Leonard W; Recchia, Angela; Ribeiro, Oscar; Riva, Emma; Rott, Christoph; Sikkes, Sietske Am; Skoog, Ingmar; Stephan, Blossom; Szewieczek, Jan; Teixeira, Laetitia; Tettamanti, Mauro; Wilczynski, Krzysztof; Sachdev, Perminder.
Afiliação
  • Leung Y; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Barzilai N; Albert Einstein College of Medicine, New York, USA.
  • Batko-Szwaczka A; Department of Geriatrics, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
  • Beker N; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Boerner K; Department of Gerontology, McCormack Graduate School, University of Massachusetts Boston, Boston, USA.
  • Brayne C; University of Cambridge, Cambridge, United Kingdom.
  • Brodaty H; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Cheung KS; University of Hong Kong (HKU), Hong Kong SAR, Hong Kong.
  • Corrada MM; University of California, Irvine, USA.
  • Crawford JD; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Galbussera AA; Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano, Italy.
  • Gondo Y; Osaka University Graduate School of Human Sciences School of Human Sciences: Osaka, Osaka, Japan.
  • Holstege H; Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Hulsman M; Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
  • Ishioka YL; O.P. Jindal Global University, Sonipat, India.
  • Jopp D; University of Lausanne, Lausanne, Switzerland.
  • Kawas CH; University of California, Irvine, USA.
  • Kaye J; NIA - sLayton Aging & Alzheimer's Disease Research Center, Oregon Health & Science University, Portland, USA.
  • Kochan NA; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Lau BH; Hong Kong Shue Yan University (HKSYU), Hong Kong SAR, Hong Kong.
  • Lipnicki DM; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Lo JW; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Lucca U; Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano, Italy.
  • Makkar SR; Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, Australia.
  • Marcon G; University of Trieste, Trieste, Italy.
  • Martin P; University of Udine, Udine, Italy.
  • Meguro K; Iowa State University, Ames, USA.
  • Milman S; Geriatric Behavioral Neurology, Tohoku University, Sendai, Japan.
  • Poon LW; Albert Einstein College of Medicine, New York, USA.
  • Recchia A; University of Georgia, Athens, USA.
  • Ribeiro O; Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano, Italy.
  • Riva E; Center for Health Technology and Services Research (CINTESIS), University of Aveiro and ICBAS-University of Porto, Porto, Portugal.
  • Rott C; Laboratory of Geriatric Neuropsychiatry, Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milano, Italy.
  • Sikkes SA; Institute of Gerontology, Heidelberg University, Heidelberg, Germany.
  • Skoog I; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
  • Stephan B; Section Clinical, Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Szewieczek J; University of Gothenburg, Gothenburg, Sweden.
  • Teixeira L; Institute for Ageing and Institute for Health & Society, Newcastle University, Newcastle, UK.
  • Tettamanti M; Department of Geriatrics, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
  • Wilczynski K; Center for Health Technology and Services Research (CINTESIS), University of Aveiro and ICBAS-University of Porto, Porto, Portugal.
  • Sachdev P; Mario Negri Institute for Pharmacological Research, Milan, Italy.
Alzheimers Dement ; 19(6): 2265-2275, 2023 06.
Article em En | MEDLINE | ID: mdl-36453627
ABSTRACT

INTRODUCTION:

There are limited data on prevalence of dementia in centenarians and near-centenarians (C/NC), its determinants, and whether the risk of dementia continues to rise beyond 100.

METHODS:

Participant-level data were obtained from 18 community-based studies (N = 4427) in 11 countries that included individuals ≥95 years. A harmonization protocol was applied to cognitive and functional impairments, and a meta-analysis was performed.

RESULTS:

The mean age was 98.3 years (SD = 2.67); 79% were women. After adjusting for age, sex, and education, dementia prevalence was 53.2% in women and 45.5% in men, with risk continuing to increase with age. Education (OR 0.95;0.92-0.98) was protective, as was hypertension (odds ratio [OR] 0.51;0.35-0.74) in five studies. Dementia was not associated with diabetes, vision and hearing impairments, smoking, and body mass index (BMI).

DISCUSSION:

Among the exceptional old, dementia prevalence remains higher in the older participants. Education was protective against dementia, but other factors for dementia-free survival in C/NC remain to be understood.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cognição / Centenários Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Aged80 / Female / Humans / Male Idioma: En Revista: Alzheimers Dement Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cognição / Centenários Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Aged80 / Female / Humans / Male Idioma: En Revista: Alzheimers Dement Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália